GSA CAPITAL PARTNERS LLP - AC IMMUNE SA ownership

AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 17 filers reported holding AC IMMUNE SA in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of AC IMMUNE SA
ValueSharesWeighting
Q4 2021$362,000
+212.1%
73,046
+334.8%
0.04%
+55.2%
Q1 2020$116,000
-57.5%
16,800
-47.7%
0.03%
-9.4%
Q4 2019$273,000
+92.3%
32,100
+12.2%
0.03%
+68.4%
Q3 2019$142,000
+29.1%
28,600
+107.2%
0.02%
+216.7%
Q3 2018$110,000
-79.0%
13,801
-72.8%
0.01%
-78.6%
Q1 2017$525,000
+14.9%
50,697
+43.9%
0.03%
+3.7%
Q4 2016$457,00035,2330.03%
Other shareholders
AC IMMUNE SA shareholders Q2 2017
NameSharesValueWeighting ↓
BVF INC/IL 7,428,379$21,170,8800.57%
Avidity Partners Management LP 2,969,800$8,463,9300.34%
PLATINUM INVESTMENT MANAGEMENT LTD 1,322,462$3,769,0170.15%
Eversept Partners, LP 124,589$355,0790.03%
COHEN LAWRENCE B 12,850$36,6230.02%
Banque Cantonale Vaudoise 80,701$2310.01%
Renaissance Technologies 425,179$1,2120.00%
Handelsbanken Fonder AB 101,064$2880.00%
Tower Research Capital LLC (TRC) 19,638$55,9680.00%
Compagnie Lombard Odier SCmA 10,000$28,5000.00%
View complete list of AC IMMUNE SA shareholders